Cerebrospinal fluid levels of myelin basic protein-like material and soluble interleukin-2 receptor in multiple sclerosis.
The presence, level and disease activity relationships of soluble interleukin-2 receptor (sIL-2R) in the cerebrospinal fluid (CSF) of multiple sclerosis (MS) patients are unresolved. We measured CSF immunoreactive myelin basic protein (MBP), a marker of acute myelin damage, and sIL-2R levels in the CSF from 11 patients with active relapsing remitting (RR) MS, five with stable RR MS, eight with chronic progressive (CP) MS, five with other neurologic diseases, and three normal controls. No measurable (less than 100 units/ml) sIL-2R was present in any of the samples. Conversely, MBP levels were elevated in the active RR group compared to the other four groups. These results indicate that, at the sensitivity of assays currently available, levels of CSF sIL-2R do not correlate with the diagnosis or disease activity of MS.
Fesenmeier
J T
JT
Department of Neurology, University of Alabama at Birmingham 35294.
Whitaker
J N
JN
Herman
P K
PK
Walker
D P
DP
D006801:Humans; D009103:Multiple Sclerosis / Q000134:cerebrospinal fluid* / Q000503:physiopathology; D004676:Myelin Basic Protein / Q000134:cerebrospinal fluid*; D015375:Receptors, Interleukin-2 / Q000134:cerebrospinal fluid*; D012008:Recurrence; D012995:Solubility
D004676:Myelin Basic Protein; D015375:Receptors, Interleukin-2